Development of diagnostic technology for graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation using a novel T cell function analysis

Development of diagnostic technology for graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation using a novel T cell function analysis - Development of diagnostic technology for GVHD using a novel T cell function analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039389

Enrollment

Registered

2020-02-04

Start date

2020-02-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic Malignancies, Aplastic Anemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1, Filling out the written informed consent form before study participation of the patients' own volition 2, Patient who will have an allogenic hematopoietic stem cell transplantation

Exclusion criteria

Exclusion criteria: Patient who are found to be inappropriate for this trial as judged by the principal investigator or the sub-investigator

Design outcomes

Primary

Measure	Time frame
the stimulus-responsive T cell rate	—

Countries

Japan

Contacts

Public ContactHiroshi Yasui

The Institute of Medical Science, The University of Tokyo Department of Hematology/Oncology, IMSUT Hospital

hiroyasu@ims.u-tokyo.ac.jp+81334438111

Outcome results